Gland Pharma Limited
GLAND
Classement en actions
#3303
Gland Pharma Limited, established in Hyderabad, India, in 1978, is a... Gland Pharma Limited, established in Hyderabad, India, in 1978, is a pharmaceutical company that specializes in the creation, production, and global distribution of generic injectable medications. Its product line features key active pharmaceutical ingredients such as heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, among others. The company's extensive therapeutic portfolio encompasses anti-infectives, anesthetics, anticoagulants, antimalarials, cardiovascular drugs, gastrointestinal treatments, pain management, hormones, fertility aids, anti-cancer agents, gynecological remedies, neurological and central nervous system medications, respiratory treatments, blood-related products, ophthalmological and otological solutions, orthopedics, hematinics, and various vitamins, minerals, and nutrients. Additionally, Gland Pharma provides contract development services. The company primarily operates on a business-to-business (B2B) model, distributing its products across major markets including the United States, Europe, Canada, Australia, India, and other international territories. Gland Pharma Limited functions as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
Prix de l'action
$32.32
Capitalisation boursière
$5.33B
Changement (1 jour)
-3.01%
Changement (1 an)
47.99%
Pays
IN
Échange Gland Pharma Limited (GLAND)
Catégorie
Healthcare
Ratio P/S pour Gland Pharma Limited (GLAND)
Ratio P/S au October 2026 TTM : 7.47
Selon les derniers rapports financiers et le cours de l'action de Gland Pharma Limited, le ratio cours/ventes actuel (TTM) est 7.47. À la fin de 2024, le ratio P/S était de 5.27.
Historique du ratio P/S pour Gland Pharma Limited de 2017 à 2026
Ratio P/S à la fin de chaque année
| Année | Ratio P/S | Changez |
|---|---|---|
| 2026 (TTM) | 7.47 | 63.72% |
| 2025 | 4.56 | -13.61% |
| 2024 | 5.27 | -9.26% |
| 2023 | 5.81 | -52.56% |
| 2022 | 12.25 | 7.08% |
| 2021 | 11.44 | 4.38% |
| 2020 | 10.96 | -26.45% |
| 2019 | 14.91 | -20.73% |
| 2018 | 18.80 | -1.35% |
| 2017 | 19.06 | 0.00% |
Ratio P/S pour des entreprises similaires ou concurrentes
| Entreprise | Ratio P/S | Différence de Ratio P/S | Pays |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | -5.46% |
IN
|
